# nView medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nview-medical

- Industry: Medical Devices & Equipment
- Headquarters: Salt Lake City, US
- Website: www.nviewmed.com
- Total disclosed funding: $1.2M
- Latest round: Seed (Aug 23, 2018)
- Investors on record: 2

## About

nView Medical Inc. develops advanced surgical imaging and navigation systems, enhancing precision and safety in pediatric surgeries through innovative technologies.nView Medical Inc. is focused on revolutionizing surgical imaging and navigation for pediatric applications. The company was founded in 2012 and is headquartered in Salt Lake City, US. Cristian Atria is the CEO and founder, who has a background in pioneering tech innovations. The company has raised USD 1.20 mn over two funding rounds, with the most recent being a Venture Debt round of USD 1.00 mn on May 9, 2019.nView Medical's primary product is the nView s1™, an innovative surgical imaging and navigation system specifically designed for pediatric applications. This system employs breakthrough 3D imaging technology to capture low-dose three-dimensional images instantly, enhancing the precision and safety of surgical procedures. The nView s1™ features true-map navigation™, which effectively acts as a GPS-like guidance tool, utilizing real anatomical images to assist surgeons during operations. By integrating imaging, tracking, and artificial intelligence technologies, the system augments surgical understanding, facilitating intraoperative planning, guidance, and quality control. The nView s1™ has been adopted by prominent healthcare institutions, including St. Louis Children’s Hospital, and serves a diverse client base across the United States, focusing on pediatric healthcare facilities that aim to improve surgical outcomes for their young patients.nView Medical's revenue model is primarily based on the sale and integration of its flagship product, the nView s1™, into healthcare facilities. The company engages in direct partnerships with hospitals and surgical centers, allowing for the implementation of their technology within surgical departments. Revenue is generated through the sale of equipment and potential additional support services related to the integration and maintenance of the nView s1™ system. The company's strategic partnerships, such as the collaboration with Orthofix, may further enhance its market reach and revenue potential. While specific pricing details for the nView s1™ and related services are not disclosed, the business structure follows a B2B model, focusing on long-term relationships with healthcare providers to promote consistent utilization of their innovative surgical solutions.nView Medical plans to expand its product offerings and development efforts surrounding the nView s1™ system, aiming to introduce new features designed to enhance surgical capabilities. Geographically, the company is targeting expansion into additional pediatric healthcare markets across the US by 2023. The recent funding of USD 1.00 mn raised in May 2019 will support these development initiatives and market expansion efforts.

## Funding rounds

- Seed, Aug 23, 2018, $1.2M — Fusion Fund, The National Science Foundation

## Investors

- Fusion Fund (https://capitalatlas.ai/funds/fusion-fund) — Seed
- The National Science Foundation — Seed